BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32414398)

  • 1. Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually.
    Campillo JT; Chesnais CB; Pion SDS; Gardon J; Kamgno J; Boussinesq M
    Parasit Vectors; 2020 May; 13(1):258. PubMed ID: 32414398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
    Nana-Djeunga HC; Bourguinat C; Pion SD; Bopda J; Kengne-Ouafo JA; Njiokou F; Prichard RK; Wanji S; Kamgno J; Boussinesq M
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2824. PubMed ID: 24762816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results.
    Fobi G; Gardon J; Kamgno J; Aimard-Favennec L; Lafleur C; Gardon-Wendel N; Duke BO; Boussinesq M
    Trans R Soc Trop Med Hyg; 2005 Apr; 99(4):279-89. PubMed ID: 15708387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplastic change in Onchocerca volvulus and its relation to ivermectin treatment.
    Duke BO; Marty AM; Peett DL; Gardo J; Pion SD; Kamgno J; Boussinesq M
    Parasitology; 2002 Nov; 125(Pt 5):431-44. PubMed ID: 12458827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.
    Gardon J; Boussinesq M; Kamgno J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO
    Lancet; 2002 Jul; 360(9328):203-10. PubMed ID: 12133654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
    Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
    PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
    Pion SD; Nana-Djeunga HC; Kamgno J; Tendongfor N; Wanji S; Njiokou F; Prichard RK; Boussinesq M
    PLoS Negl Trop Dis; 2013; 7(2):e2084. PubMed ID: 23469307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
    Kamgno J; Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
    Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):496-504. PubMed ID: 15186939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
    Duke BO
    Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.
    Awadzi K; Opoku NO; Attah SK; Lazdins-Helds J; Kuesel AC
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2953. PubMed ID: 24968000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.
    Eisenbarth A; Achukwi MD; Renz A
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004392. PubMed ID: 26926855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment.
    Bourguinat C; Pion SD; Kamgno J; Gardon J; Duke BO; Boussinesq M; Prichard RK
    PLoS Negl Trop Dis; 2007 Aug; 1(1):e72. PubMed ID: 17989786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of four years of large-scale ivermectin treatment with low therapeutic coverage on the transmission of Onchocerca volvulus in the Mbam valley focus, central Cameroon.
    Pion SD; Clément MC; Boussinesq M
    Trans R Soc Trop Med Hyg; 2004 Sep; 98(9):520-8. PubMed ID: 15251400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
    Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
    Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point prevalence mapping reveals hotspot for onchocerciasis transmission in the Ndikinimeki Health District, Centre Region, Cameroon.
    Aza'ah RA; Sumo L; Ntonifor NH; Bopda J; Bamou RH; Nana-Djeunga HC
    Parasit Vectors; 2020 Oct; 13(1):519. PubMed ID: 33066826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
    Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
    BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled prospective trial of the prophylactic effect of a single dose of ivermectin against Onchocerca volvulus.
    Boussinesq M; Chippaux JP
    Parasite; 2001 Sep; 8(3):255-9. PubMed ID: 11584757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi.
    Tchakouté VL; Bronsvoort M; Tanya V; Renz A; Trees AJ
    Parasitology; 1999 Feb; 118 ( Pt 2)():195-9. PubMed ID: 10028534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.